Dr. Ajeet Gajra, MD

Dr. Gajra practices at Hematology-Oncology Associates of CNY in East Syracuse, New York.

Dr. Gajra's NPI, 1538197975, was assigned on June 28, 2006. Dr. Gajra graduated from Maulana Azad Medical College in 1993. Dr. Gajra's New York license number on file is 240770.

Dr. Gajra's primary practice is Hematology-Oncology Associates of CNY, at 5008 Brittonfield Pkwy, East Syracuse, NY 13057 in Onondaga County. The practice phone is (315) 472-7504.

Dr. Gajra's primary practice is Hematology-Oncology Associates of CNY in East Syracuse, New York. Dr. Gajra is also affiliated with Upstate University Hospital. The medical group on file is Hematology-Oncology Associates of CNY. Dmand AI also links Dr. Gajra to 2 more hospitals, 2 group practices and clinics, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gajra practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Gajra's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Gajra is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Gajra's licenses on file in 2 states: New York and Indiana.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Gajra treats.

CMS data shows 17,544 Medicare services from Dr. Gajra across 46 procedure codes in 2024, for 588 Medicare patients. Medicare paid $188,812 for them.

CMS counts 588 Medicare patients who saw Dr. Gajra in 2024. The largest group is 65 to 74, with 249 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gajra's median patient age at 70, with 52% women.

In 2024, Dr. Gajra wrote 242 Medicare Part D claims for 73 patients. 78% of them were for generic drugs. CMS names the drug for 71 of them, across 5 drugs with 11 or more claims each, at $149,479 in total drug cost. In 2023, CMS named 73 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Gajra for performance year 2024, reported as part of a group. Dr. Gajra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gajra as offering telehealth.

Dmand AI links 137 papers to Dr. Gajra, published from 2007 to 2025. 2020 was the busiest year, with 11. The most frequent topics are Lung Neoplasms, Antineoplastic Agents and Antineoplastic Combined Chemotherapy Protocols. Dr. Gajra has published most often in J Geriatr Oncol. Dr. Gajra's most frequent co-authors are Heidi D. Klepin, MD, Supriya Gupta Mohile, MD and Stuart M. Lichtman, MD.

Dmand AI links Dr. Gajra to 13 clinical trials, 6 of them phase 3 studies. 5 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Adenocarcinoma of Lung. Alliance for Clinical Trials in Oncology sponsors the most, 4.

CMS Open Payments shows 117 general payments to Dr. Gajra from 31 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 73% of the total. AstraZeneca Pharmaceuticals LP paid the most, $30,799. It also lists 2 research payments totaling $4,874 from 2016 to 2017.

Dmand AI lists 3 awards for Dr. Gajra, most recently ACP Fellow in 2012.

Dr. Gajra graduated from Maulana Azad Medical College in 1993. Dr. Gajra is a member of AOA, ACP, ASCO, IASLC- International Association for Study of Lung Cancer and SIOG: Society of Geriatric Oncology.

Dr. Gajra is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.